Hepsor AS-i auditeer
Hepsor AS-i auditeeritud majandusaasta aruanne 2023
April 19, 2024 00:00 ET | HEPSOR AS
Hepsor AS-i juhatus on koostanud 2023. aasta majandusaasta auditeeritud aruande. Võrreldes 14. veebruaril 2024 avaldatud auditeerimata majandustulemustega ei ole auditeeritud aruandes finantstulemuste...
Hepsor AS 2023 audit
Hepsor AS 2023 audited annual report
April 19, 2024 00:00 ET | HEPSOR AS
The Management Board of Hepsor AS has prepared the audited annual report for 2023. Compared to the unaudited interim report published on 14 February 2024, there are no material differences in the...
Hepsor ASi 2023. aas
Hepsor ASi 2023. aasta IV kvartali ja 12. kuu konsolideeritud auditeerimata vahearuanne
February 14, 2024 00:00 ET | HEPSOR AS
Hepsori 2023. aasta konsolideeritud müügitulu ulatus 41,1 miljoni euroni ja puhaskasumiks kujunes 3,5 miljonit eurot (sh emaettevõtte omanikele kuuluv osa 1,2 miljonit eurot). 2023. aasta neljanda...
Hepsor AS consolidat
Hepsor AS consolidated unaudited interim report for Q4 and 12 months of 2023
February 14, 2024 00:00 ET | HEPSOR AS
Hepsor's 2023 consolidated revenue amounted to 41.1 million euros, with a net profit of 3.5 million euros (including a share of 1.2 million euros for the parent company's owners). The consolidated...
Hepsor ASi 2024. aas
Hepsor ASi 2024. aasta finantskalender
December 21, 2023 00:00 ET | HEPSOR AS
2024. aastal plaanib Hepsor AS avalikustada konsolideeritud majandustulemused alljärgnevalt: 14. veebruar 2024 2023. aasta 12 kuu ja IV kvartali auditeerimata vahearuanne 19. aprill 2024 2023....
Hepsor AS financial
Hepsor AS financial calendar 2024
December 21, 2023 00:00 ET | HEPSOR AS
In 2024, Hepsor AS plans to disclose the consolidated financial results as follows: 14 February 2024 Unaudited interim report for Q4 and 12 months 2023 19 April 2024 Audited annual report for 2023...
Novel Clinic Assets
Novel Clinic Assets OÜ on Hepsor AS sidusettevõtte Hepsor P113 OÜ kohta esitanud kohtuhagi
December 15, 2023 00:00 ET | HEPSOR AS
Hepsor AS-i 45%-lise osalusega sidusettevõte Hepsor P113 OÜ ütles 4. septembril üles üürilepingu Novel Clinic Assets OÜ-ga. Hepsor P113 OÜ-le kuulub ca 4 000 m2 üüritava pinnaga ärihoone Tallinnas,...
Novel Clinic Assets
Novel Clinic Assets OÜ has filed a lawsuit against Hepsor P113 OÜ, an affiliate of Hepsor AS.
December 15, 2023 00:00 ET | HEPSOR AS
Hepsor P113 OÜ, an affiliate of Hepsor AS with a 45% shareholding, terminated the lease agreement with Novel Clinic Assets OÜ. Hepsor P113 OÜ owns a commercial building with a leasable area of ca...
Hepsor ASi tütarette
Hepsor ASi tütarettevõte Hepsor JG SIA sõlmis Annanhof Majas projekti ehituse finantseerimiseks laenulepingu summas 4 miljonit eurot
December 11, 2023 00:00 ET | HEPSOR AS
08. detsembril 2023 allkirjastasid Hepsor ASi tütarettevõte Hepsor JG SIA ja Bigbank AS Läti filiaal laenulepingu summas 4 miljonit eurot. Kolmeaastase tähtajaga laenu eesmärk on finantseerida...
Hepsor JG SIA, Hepso
Hepsor JG SIA, Hepsor AS group company, signed 4 million euro loan agreement for financing the construction of Annenhof Majas project
December 11, 2023 00:00 ET | HEPSOR AS
Hepsor JG SIA, Hepsor AS group company, and Latvian affiliate of Bigbank AS signed a 4 million loan agreement on 08 December 2023. The purpose of the three-year loan is to finance the construction of...